• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

CPIC CYP2D6 and Codeine Guidelines: 2014 Updates

Home / News / CPIC CYP2D6 and Codeine Guidelines: 2014 Updates

Genelex Blog

CPIC CYP2D6 and Codeine Guidelines: 2014 Updates

The Clinical Pharmacogenetics Implementation Consortium (CPIC) recently published its 2014 update to their Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy. This builds on their 2012 guidelines and incorporates new information, including the FDA’s recent warnings regarding the use of codeine following tonsillectomies in children. The new guidelines also expand the recommendations section to include new considerations and notes on other opioids metabolized by CYP2D6 such as oxycodone, hydrocodone and tramadol.

The CPIC was formed in 2009 as part of PharmGKB and the Pharmacogenomics Research Network. CPIC Guidelines are published in peer-reviewed journals in order to help clinicians understand how to use pharmacogenetic test results.

Codeine is an opioid analgesic that is also sometimes used for its antitussive properties. Like all opioids, codeine can be associated with adverse side effects, including severe effects such as respiratory depression. Codeine is metabolized by the genetically variable CYP2D6 enzyme. The CPIC recommends using alternative medications in CYP2D6 poor or ultrarapid metabolizers.

To download a copy of the new paper, go to http://bit.ly/1iUbAmw.

Genelex Resources

Affected Conditions
Affected Drugs
Info for Providers
Frequently Asked Questions
Contact Genelex
Join Our Mailing List

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.